Why the study?
Does stabilized infective endocarditis alter heparin responsiveness during cardiopulmonary bypass?
Does stabilized infective endocarditis alter heparin responsiveness during cardiopulmonary bypass?
Patients with stabilized infective endocarditis exhibit reduced heparin responsiveness during cardiopulmonary bypass, suggesting a potential need for antithrombin III concentrate supplementation.
Answers are grounded in this paper and cite their sources.
Stabilized IE may require adjusted heparin dosing during CPB; hypothesis-generating for antithrombin III supplementation, needs prospective confirmation.
Heparin responsiveness during CPB was significantly reduced in the IE group, and it seems to be associated with preoperative hypercoagulability and reduced antithrombin III activity. Therapeutic measures such as the administration of antithrombin III concentrate should be considered in these patients even when they are in a stabilized condition without active inflammation.
No takes yet. Share an insight, caveat, or question.
Na et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: